Cargando…

Elevated tumor markers for monitoring tumor response to immunotherapy

BACKGROUND: As the immune-related response evaluation criteria in solid tumors (irRECIST) by imaging greatly underestimated the objective response to immunotherapy, we established the response evaluation criteria in solid tumors based on tumor markers (RecistTM) to explore whether RecistTM can compe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yi, Jiang, Xiaolin, Liu, Yun, Huang, Huan, Xiong, Yanli, Xiao, He, Gong, Kan, Li, Xuemei, Kuang, Xunjie, Yang, Xueqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011015/ https://www.ncbi.nlm.nih.gov/pubmed/35434583 http://dx.doi.org/10.1016/j.eclinm.2022.101381

Ejemplares similares

Serum carcinoembryonic antigen elevation in benign lung diseases
por: Yang, Yi, et al.
Publicado: (2021)

Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses
por: Zhang, Qin, et al.
Publicado: (2023)

Nm23-H1 is involved in the repair of ionizing radiation-induced DNA double-strand breaks in the A549 lung cancer cell line
por: Sheng, Ya, et al.
Publicado: (2018)

Regulation mechanism of ferroptosis and its research progress in tumor immunotherapy
por: Xu, Jing, et al.
Publicado: (2022)

Listeria monocytogenes: a promising vector for tumor immunotherapy
por: Ding, Yi-Dan, et al.
Publicado: (2023)

Late relapsing germ cell tumors with elevated tumor markers
por: Che, Yue, et al.
Publicado: (2021)

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
por: Xu, Shumin, et al.
Publicado: (2023)

Emerging biomaterials for tumor immunotherapy
por: Xiao, Minna, et al.
Publicado: (2023)

Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion
por: Gu, Yan, et al.
Publicado: (2016)

Metabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy
por: Dastmalchi, Farhad, et al.
Publicado: (2021)

Elevated tumor markers in a benign lung disease
por: Chen, Quan, et al.
Publicado: (2021)

Tumor-mutation burden as a marker for immunotherapy of pancreatic cancer: the case report and literature review
por: Zhu, Peng-Fei, et al.
Publicado: (2021)

Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy
por: Groux-Degroote, Sophie, et al.
Publicado: (2021)

Immunotherapy of targeting MDSCs in tumor microenvironment
por: Sui, Hongshu, et al.
Publicado: (2022)

Monitoring Regulatory Immune Responses in Tumor Immunotherapy Clinical Trials
por: Olson, Brian M., et al.
Publicado: (2013)

Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy
por: Nguyen, Anh, et al.
Publicado: (2020)

Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor
por: Wei, Xiao, et al.
Publicado: (2022)

Tumor markers used in monitoring the tumor recurrence in patients with colorectal cancer
por: BURZ, CLAUDIA, et al.
Publicado: (2016)

Two Patients with Extremely Elevated Tumor Markers: Where Is the Malignancy?
por: van der Veek, Patrick P. J., et al.
Publicado: (2011)

Neoantigen vaccine: an emerging tumor immunotherapy
por: Peng, Miao, et al.
Publicado: (2019)

Role of ferroptosis on tumor progression and immunotherapy
por: Gong, Deting, et al.
Publicado: (2022)

Changes of Tumor Markers in Patients with Lung Cancer after Immunotherapy and Their Link with Inflammation in the Body
por: Liu, LiWei, et al.
Publicado: (2022)

Targeting tumor-associated macrophages to synergize tumor immunotherapy
por: Xiang, Xiaonan, et al.
Publicado: (2021)

Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC
por: Gong, Xiangjin, et al.
Publicado: (2023)

In Vivo Monitoring of Natural Killer Cell Trafficking During Tumor Immunotherapy
por: Sta Maria, Naomi S, et al.
Publicado: (2014)

Peptide libraries for comprehensive coverage of the tumor mutanome in immune monitoring and immunotherapy
por: Castro, Aaron, et al.
Publicado: (2015)

Noninvasive interrogation of CD8(+) T cell effector function for monitoring early tumor responses to immunotherapy
por: Zhou, Haoyi, et al.
Publicado: (2022)

USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy
por: Xiong, Wenjun, et al.
Publicado: (2022)

The significance of elevated tumor markers among patients with interstitial lung diseases
por: Kwon, Byoung Soo, et al.
Publicado: (2022)

Tumor Antigenicity and Approaches to Tumor Immunotherapy
por: Hewitt, H. B.
Publicado: (1980)

Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy
por: Xiao, Chu, et al.
Publicado: (2022)

Dynamic monitoring of serum tumor markers as prognostic factors in patients with advanced non-small-cell lung cancer treated with first-line immunotherapy: a multicenter retrospective study
por: Yang, Xiongwen, et al.
Publicado: (2023)

Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy
por: Feng, Hai, et al.
Publicado: (2022)

Mixed germ cell tumor infiltrating the pineal gland without elevated tumor markers: illustrative case
por: Shiomi, Koji, et al.
Publicado: (2021)

NK cell-based tumor immunotherapy
por: Zhang, Hao, et al.
Publicado: (2023)

Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More
por: Li, Yang, et al.
Publicado: (2021)

Advances of DNA Damage Repair-Related Drugs and Combination With Immunotherapy in Tumor Treatment
por: Wang, Yumin, et al.
Publicado: (2022)

Tumor therapeutic response monitored by telemetric temperature sensing, a preclinical study on immunotherapy and chemotherapy
por: Shao, Qi, et al.
Publicado: (2023)

Tumor vessel normalization and immunotherapy in gastric cancer
por: Yu, Xianzhe, et al.
Publicado: (2022)

A Sensitive IHC Method for Monitoring Autophagy-Specific Markers in Human Tumor Xenografts
por: He, Helen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pt85flr0h32iqq43nksgej4fg1